Are We Ready for Biosimilars in Gastroenterology?

Biologics are large complex molecules that are produced in living systems. They have revolutionised the treatment of patients suffering from various diseases, including inflammatory bowel disease. However, in many parts of the world, patient access to biologics has been hampered, mainly because of t...

Full description

Bibliographic Details
Main Authors: Muhammad Ilham Abdul Hafidz, Thevaraajan Jayaraman, Raja Affendi Raja Ali, Yeong Yeh Lee
Format: Article
Language:English
Published: European Medical Journal 2017-12-01
Series:European Medical Journal Gastroenterology
Subjects:
Online Access:https://www.emjreviews.com/gastroenterology/article/are-we-ready-for-biosimilars-in-gastroenterology/